MCID: MYL001
MIFTS: 46

Myelitis malady

Categories: Rare diseases, Neuronal diseases

Aliases & Classifications for Myelitis

About this section

Aliases & Descriptions for Myelitis:

Name: Myelitis 10 45 47 12 36 65

Classifications:



External Ids:

Disease Ontology10 DOID:322
MeSH36 D009187
NCIt42 C26832
UMLS65 C0026975

Summaries for Myelitis

About this section
Wikipedia:68 Myelitis involves the infection or the inflammation of the white matter or gray matter of the spinal... more...

MalaCards based summary: Myelitis is related to idiopathic acute transverse myelitis and atopic dermatitis. An important gene associated with Myelitis is AQP4 (Aquaporin 4), and among its related pathways are Platelet Aggregation Inhibitor Pathway, Pharmacodynamics and MAP2K and MAPK activation. Affiliated tissues include spinal cord, brain and lung, and related mouse phenotype vision/eye.

Related Diseases for Myelitis

About this section

Diseases related to Myelitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 260)
idRelated DiseaseScoreTop Affiliating Genes
1idiopathic acute transverse myelitis34.0APOA1, AQP4
2atopic dermatitis29.0AQP4, MBP, MOG
3myocardial infarction27.8APOA1, APOH, ITGA2B, ITGB3, MTHFR
4transverse myelitis12.3
5acute transverse myelitis12.2
6secondary acute transverse myelitis12.1
7radiation myelitis12.0
8foix-alajouanine syndrome11.5
9neuromyelitis optica10.8
10encephalitis10.6
11acute disseminated encephalomyelitis10.6
12tropical spastic paraparesis10.5
13nephrolithiasis10.5AQP4, MTHFR
14spinocerebellar atrophy10.4APOH, MTHFR
15liver failure acute infantile10.4APOH, MTHFR
16catatrichy10.4APOH, MTHFR
17pregnancy loss, recurrent 110.4APOH, MTHFR
18systemic lupus erythematosus10.4
19lupus erythematosus10.4
20malignant hypertensive renal disease10.4AQP4, MOG
21sesame syndrome10.4APOH, MTHFR
22maple bark strippers' lung10.4APOH, MTHFR
23ischemic optic neuropathy10.4APOA1, ITGB3
24meningoencephalitis10.4
25bubonic plague10.4APOH, ITGB3
26eccrine sweat gland neoplasm10.3APOH, MTHFR
27colonic pseudo-obstruction10.3APOH, MTHFR
28vertebral artery insufficiency10.3APOH, MTHFR
29multiple epiphyseal dysplasia10.3APOA1, MTHFR
30withdrawal disorder10.3APOH, ITGB3
31oral squamous cell carcinoma10.3ITGB3, MTHFR
32protein s deficiency10.3APOH, MTHFR
33pyridoxamine 5'-phosphate oxidase deficiency10.3ITGA2B, ITGB3
34fetal antihypertensive drugs syndrome10.3ITGA2B, ITGB3
35short stature due to primary acid-labile subunit deficiency10.3ITGA2B, ITGB3
36nutmeg liver10.3APOH, MTHFR
37cervicitis10.2
38blood platelet disease10.2ITGA2B, ITGB3
39pneumonia10.2
40learning disability10.2ITGA2B, ITGB3
41acral lentiginous melanoma10.2AQP4, MBP
42autoimmune disease of cardiovascular system10.2ITGA2B, ITGB3
43cogan syndrome10.2AQP4, MBP
44thrombophilia due to activated protein c resistance10.1APOH, MTHFR
45hepatitis10.1
46choledochal cyst10.1AQP4, HLA-DPB1, MOG
47bartholin's gland adenoma10.1AQP4, MBP
48optic neuritis10.1
49neuritis10.1
50retinitis pigmentosa10.1APOH, MTHFR

Graphical network of the top 20 diseases related to Myelitis:



Diseases related to myelitis

Symptoms for Myelitis

About this section

Drugs & Therapeutics for Myelitis

About this section

Drugs for Myelitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 129)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Mitoxantroneapproved, investigationalPhase 425765271-80-94212
Synonyms:
1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone
1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE
1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione
1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione
1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon
1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione
1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione
1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone
1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione
137635-96-2
2fum
5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone
65271-80-9
70476-82-3
70476-82-3 (hydrochloride)
70711-41-0
70711-41-0 (acetate)
70945-62-9
9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9CI)
AB00053716
AC1L1HNY
AN-584/42007670
BIDD:PXR0181
BPBio1_000627
BRD-K21680192-300-05-2
BRD-K21680192-300-07-8
BRN 2795126
BSPBio_000569
BSPBio_003160
C11195
C22H28N4O6
CAS-70476-82-3
CCRIS 7604
CHEBI:50729
CHEMBL58
CID4212
D08224
DB01204
DHAD
DHAQ
DHAQ (*Diacetate salt*)
DHAQ HCl
Dihydroxyanthraquinone
DivK1c_000516
HMS2090D05
IDI1_000516
KBio1_000516
KBio2_002135
KBio2_004703
KBio2_007271
KBio3_002660
KBioGR_001531
KBioSS_002135
LS-20638
Liposome Encapsulated Mitoxantrone (LEM)
Lopac-M-6545
Lopac0_000779
MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE
MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE
MIX
MLS002703044
 
Misostol
Misostol (TN)
Mitox
Mitoxanthrone
Mitoxantron
Mitoxantrona
Mitoxantrona [INN-Spanish]
Mitoxantrone
Mitoxantrone (INN)
Mitoxantrone (free base)
Mitoxantrone 2HCl
Mitoxantrone HCl
Mitoxantrone Hydrochloride
Mitoxantrone [INN]
Mitoxantrone dihydrochloride
Mitoxantrone hydrochloride
Mitoxantronum
Mitoxantronum [INN-Latin]
Mitozantrone
Mitozantrone hydrochloride
MolPort-003-849-239
NCGC00015693-01
NCGC00015693-02
NCGC00015693-04
NCGC00162251-01
NCI60_002276
NCI60_002535
NChemBio.2007.10-comp17
NINDS_000516
NSC 279836
NSC-279836
NSC-287836
NSC-299195
NSC-301739
NSC-301739D
NSC279836
NSC299195
NSC301739
Neuro_000153
Novantron
Novantrone
Novantrone(R) (mitoxantrone for injection concentrate)
Prestwick0_000385
Prestwick1_000385
Prestwick2_000385
Prestwick3_000385
S2485_Selleck
SMP2_000179
SMR001549953
SPBio_000756
SPBio_002490
SR-01000076001
SR-01000076001-7
STK631833
Spectrum2_000908
Spectrum3_001590
Spectrum4_000866
Spectrum5_001205
Spectrum_001655
UNII-BZ114NVM5P
VU0244399-2
mitoxantrone
2
MethylprednisoloneapprovedPhase 4, Phase 3, Phase 1, Phase 2108283-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
A-methapred
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Depo-medrol
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Solu-medrol
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
3
PrednisoloneapprovedPhase 4, Phase 3, Phase 1, Phase 2108250-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
Flo-pred
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
MLS001304083
 
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
Millipred
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Omnipred
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
4
Interferon beta-1aapproved, investigationalPhase 4, Phase 2194145258-61-36438354
Synonyms:
145258-61-3
Avonex
Avonex (TN)
Avonex Pen
Belerofon
D04554
Extavia
 
Fibroblast interferon
IFN-beta
Interferon beta precursor
Interferon beta-1a
Interferon beta-1a (USAN)
Interferon beta-1a (genetical recombination)
Interferon beta-1a (genetical recombination) (JAN)
Rebif
Rebif Rebidose
5
ZincapprovedPhase 414777440-66-623994, 32051
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
6
DalfampridineapprovedPhase 4, Phase 262504-24-51727
Synonyms:
.gamma.-Aminopyridine
275875_ALDRICH
36687_FLUKA
36687_RIEDEL
4 AP
4 Aminopyridine
4 Aminopyridine Sustained Release
4-AP
4-Aminopyridine
4-Aminopyridine 10
4-Aminopyridine Sustained Release
4-Pyridinamine
4-Pyridylamine
4-aminopyridine
5-22-09-00106 (Beilstein Handbook Reference)
504-24-5
A 0152
A0414
A78403_ALDRICH
AB1004971
AC-907/25014071
AC1L1C3R
AC1Q52BM
AI3-52547
AKOS000119896
Amaya
Amino-4 pyridine
Amino-4-Pyridine
Ampydin
Ampyra
Avitrol
Avitrol 200
BB_SC-6974
BRN 0105782
BSPBio_001562
Bio1_000353
Bio1_000842
Bio1_001331
Bio2_000282
Bio2_000762
C13728
C5H6N2
CHEBI:34385
CHEMBL284348
CID1727
Caswell No. 038
Compound 1861
D015761
D04127
Dalfampridine
DivK1c_000572
EINECS 207-987-9
EL-970
EPA Pesticide Chemical Code 069201
EU-0100032
FT-0083754
Fampridina
Fampridine
Fampridine (USAN/INN)
Fampridine SR
Fampridine [USAN:INN]
Fampridine-PR
Fampridine-SR
Fampridinum
Fampyra
HC150041
HMS1361O04
HMS1791O04
HMS1921H15
HMS1989O04
HMS2092F05
HMS501M14
HSDB 6037
IDI1_000572
IDI1_034032
InChI=1/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7
 
KBio1_000572
KBio2_000282
KBio2_000635
KBio2_002850
KBio2_003203
KBio2_005418
KBio2_005771
KBio3_000563
KBio3_000564
KBio3_001888
KBioGR_000282
KBioGR_001505
KBioSS_000282
KBioSS_000635
LS-130202
Lopac-A-0152
Lopac0_000032
MLS000069400
Mi-W-3
MolPort-000-146-022
N07XX07
NCGC00015009-01
NCGC00015009-03
NCGC00015009-12
NCGC00024890-01
NCGC00024890-02
NCGC00024890-03
NCGC00024890-04
NCGC00024890-05
NCGC00024890-06
NCGC00024890-07
NCGC00024890-08
NCGC00024890-09
NCGC00024890-10
NINDS_000572
NSC 15041
NSC15041
Neurelan
Neurelan (TN)
P-Aminopyridine
PYRIDINE,4-AMINO
Philips 1861
Phillips 1861
Pimadin (free base)
Prc 1237
Pymadin
Pymadine
RCRA waste no. P008
SDCCGMLS-0066228.P001
SMR000058211
SPBio_001486
SPECTRUM1501130
STK298717
Spectrum2_001413
Spectrum3_000914
Spectrum4_001013
Spectrum5_001501
Spectrum_000155
Sustained Release, 4-Aminopyridine
TL8003344
Tocris-0940
UNII-BH3B64OKL9
UPCMLD-DP125
UPCMLD-DP125:001
VMI 10-3
VMI 103
VMI-10-3
VMI-103
VMI103
WLN: T6NJ DZ
[J.Pharmacol.Exp.Ther. 275:864 (1995)]
gamma-Aminopyridine
nchem.892-comp4
p-Aminopyridine
p-Aminopyridine [UN2671] [Poison]
p-Aminopyridine [UN2671] [Poison]
pyridin-4-amine
pyridin-4-ylamine
7
NeomycinapprovedPhase 4421404-04-28378
Synonyms:
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
11025-81-3
119-04-0
1393-86-8
1404-04-2
1405-10-3 (sulfate (salt))
4-18-00-07476 (Beilstein Handbook Reference)
72131_FLUKA
AB00443887
AC1L1QVH
Actilin
Actiline
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRN 0101621
BSPBio_000296
C01737
C23H46N6O13
C25H50N6O13
CCRIS 5462
CHEBI:7508
CID8378
Caswell No. 595
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D05140
DB00452
DB00994
EINECS 204-292-2
EINECS 215-766-3
EPA Pesticide Chemical Code 006303
Endomixin
Enterfram
Fradiomycin
Fradiomycin B
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
Framygen
 
Fraquinol
HMS2089P15
HSDB 3242
LS-96091
LS-96095
MolPort-003-938-736
Myacine
Myacyne
Mycifradin
Myciguent
N1142_SIGMA
NCGC00179612-01
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
NEOMYCIN SULFATE
NMY
Neo-Fradin
Neo-Rx
Neo-fradin
Neobiotic
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
Neomycin B Sulfate
Neomycin B sulfate
Neomycin Sulfate
Neomycin Sulphate
Neomycin solution
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
PIMAVECORT
Prestwick3_000158
ST075177
Soframycin
Soframycin Ophthalmic
Soframycine
Theraplusplus Plus
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297
USAF CB-19
VONAMYCIN
Vonamycin powder V
neomycin
8
Phenolapproved, experimentalPhase 443108-95-2996
Synonyms:
Acide carbolique
Acide phenique
Anbesol
Aseptil Rojo
Benzenol
Benzophenol
Campho-phenique cold sore gel
Campho-phenique gel
Campho-phenique liquid
Carbolic acid
Carbolic acid liquid
Carbolic oil
Carbolicum acidum
Carbolsaeure
Carbolsaure
Care One Sore Throat
Castellani Paint
Castellani Paint 1.5%
Cepastat Cherry
Cepastat Extra Strength
Cepastat lozenges
Chloraseptic Sore Throat
Chloraseptic Sore Throat Cherry
Chloraseptic Sore Throat Citrus
Chloraseptic Sore Throat Menthol
Chloraseptic Warming Sore Throat
Cuticura pain relieving ointment
Dg Health Sore Throat
Equaline Sore Throat
Equate Sore Throat
Fenol
Fenolo
Fenosmolin
Fenosmoline
Good Neighbor Pharmacy Sore Throat
Good Sense Sore Throat
Healthy Accents Sore Throat
Hydroxy-benzene
Hydroxybenzene
IPH
IZAL
Karbolsaeure
Leader Sore Throat
Liquefied phenol
Liquid phenol
 
Liquified phenol
Monohydroxy benzene
Monohydroxybenzene
Monophenol
Oral Relief
Oxybenzene
PHOH
Paoscle
Phenic
Phenic Acid
Phenic acid
Phenic alcohol
Phenol
Phenol alcohol
Phenol homopolymer
Phenol liquid
Phenol molten
Phenol polymer-bound
Phenol solution
Phenol synthetic
Phenolated water
Phenolated water for disinfection
Phenole
Phenosmolin
Phenyl alcohol
Phenyl hydroxide
Phenylic Acid
Phenylic acid
Phenylic alcohol
Rx Act Sore Throat
Smart Sense Sore Throat
Sore Throat
Sore Throat Cherry
Sore Throat Menthol
Sore Throat ReadyInCase
Sore Throat Relief
Sore Throat Relief Cherry
Sore Throat Spray
Sore Throat Spray Cherry
Sore Throat cherry
Sore Throat spray
Sunmark Sore Throat
Synthetic phenol
Tea polyphenol
Throat Relief
Topcare Sore Throat
9Trace ElementsPhase 43900
10Nucleic Acid Synthesis InhibitorsPhase 4, Phase 2, Phase 3, Phase 03836
11Zinc SulfatePhase 464
12Immunosuppressive AgentsPhase 4, Phase 2, Phase 3, Phase 110422
13MicronutrientsPhase 43901
14VaccinesPhase 4, Phase 3, Phase 2, Phase 16085
15Interferon-betaPhase 4, Phase 2253
16Adjuvants, ImmunologicPhase 4, Phase 21783
17PENTAPhase 4, Phase 3109
18AntimetabolitesPhase 4, Phase 2, Phase 3, Phase 09454
19Antirheumatic AgentsPhase 4, Phase 2, Phase 3, Phase 18496
20Dermatologic AgentsPhase 4, Phase 2, Phase 34555
21Pharmaceutical SolutionsPhase 4, Phase 3, Phase 2, Phase 17004
22Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3, Phase 2440
23ImmunoglobulinsPhase 4, Phase 3, Phase 2, Phase 14477
24Prednisolone phosphatePhase 4, Phase 3, Phase 1, Phase 21082
25AntibodiesPhase 4, Phase 3, Phase 2, Phase 14477
26Protective AgentsPhase 4, Phase 3, Phase 15651
27AntiemeticsPhase 4, Phase 3, Phase 13213
28Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 18478
29Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 14256
30Prednisolone hemisuccinatePhase 4, Phase 3, Phase 1, Phase 21082
31Topoisomerase InhibitorsPhase 44081
32Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 118510
33interferonsPhase 4, Phase 21930
34AnalgesicsPhase 49358
35Immunologic FactorsPhase 4, Phase 3, Phase 2, Phase 118483
36glucocorticoidsPhase 4, Phase 3, Phase 13896
37Gastrointestinal AgentsPhase 4, Phase 3, Phase 2, Phase 16401
38Methylprednisolone HemisuccinatePhase 4, Phase 3, Phase 1, Phase 21082
39Neuroprotective AgentsPhase 4, Phase 3, Phase 11376
40Anti-Infective AgentsPhase 4, Phase 2, Phase 3, Phase 017220
41Prednisolone acetatePhase 4, Phase 3, Phase 1, Phase 21082
42Hormone AntagonistsPhase 4, Phase 3, Phase 110002
43Methylprednisolone acetatePhase 4, Phase 3, Phase 1, Phase 21082
44Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 19988
45HormonesPhase 4, Phase 3, Phase 111748
46Antiviral AgentsPhase 4, Phase 2, Phase 3, Phase 08071
47Potassium Channel BlockersPhase 4, Phase 2151
48Contraceptives, OralPhase 4, Phase 23734
49PolymyxinsPhase 450
50Polymyxin BPhase 436

Interventional clinical trials:

(show top 50)    (show all 192)
idNameStatusNCT IDPhase
1Long Term Study of Avonex Therapy Following a First Attack of Multiple SclerosisCompletedNCT00179478Phase 4
2A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease)CompletedNCT00304291Phase 4
3Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During RelapseCompletedNCT00753792Phase 4
4Immunogenicity of Monovalent Type 2 Oral Poliovirus VaccineCompletedNCT02643368Phase 4
5Polio End-game Strategies - Poliovirus Type 2 Challenge StudyCompletedNCT02189811Phase 4
6Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in JapanCompletedNCT02005536Phase 4
7IPV Clinical Trial - The GambiaCompletedNCT01847872Phase 4
8Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV VaccineCompletedNCT01831050Phase 4
9Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus VaccinesCompletedNCT01616693Phase 4
10Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRECompletedNCT01546909Phase 4
11Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis VaccineCompletedNCT01475539Phase 4
12Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination CourseCompletedNCT01457547Phase 4
13Regulatory Post-Marketing Surveillance Study for TETRAXIM™CompletedNCT01437423Phase 4
14Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™CompletedNCT01358825Phase 4
15Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted AdultsCompletedNCT01323959Phase 4
16A Safety Study of IMOVAX Polio Vaccine in Selected Cities in ChinaCompletedNCT01278433Phase 4
17A Study of the Safety of IMOVAX Polio™ in ChinaCompletedNCT01244464Phase 4
18Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in RussiaCompletedNCT01094171Phase 4
19Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of AgeCompletedNCT01031303Phase 4
20Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in InfantsCompletedNCT00753649Phase 4
21Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio VaccineCompletedNCT00635128Phase 4
22Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old ChildrenCompletedNCT00611559Phase 4
23Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio VaccineCompletedNCT00514059Phase 4
24Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy InfantsCompletedNCT00325156Phase 4
25Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis VaccineCompletedNCT00304265Phase 4
26Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in ThailandCompletedNCT00255021Phase 4
27Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio VaccineRecruitingNCT02643446Phase 4
28Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryRecruitingNCT02422264Phase 4
29To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in PakistanRecruitingNCT01908114Phase 4
30Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum DisordersRecruitingNCT02021825Phase 4
31Intestinal and Humoral Immunity of Sequential Polio Vaccination SchedulesActive, not recruitingNCT02412514Phase 4
32A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in LithuaniaNot yet recruitingNCT02582255Phase 4
33A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of AgeNot yet recruitingNCT02580201Phase 4
34Safety and Efficacy of Sustained Release Dalfampridine in Transverse MyelitisTerminatedNCT01446575Phase 4
35Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.WithdrawnNCT00037115Phase 4
36Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801CompletedNCT01604746Phase 3
37Immunogenicity of Intramuscular Inactivated Poliovirus VaccineCompletedNCT02291263Phase 3
38The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)CompletedNCT02231632Phase 2, Phase 3
39Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa VaccinationCompletedNCT01983540Phase 3
40Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at BirthCompletedNCT01948193Phase 3
41Immunogenicity of Inactivated and Live Polio VaccinesCompletedNCT01813604Phase 3
42Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese ToddlersCompletedNCT01577732Phase 3
43Intravenous Immunoglobulins for Post-Polio SyndromeCompletedNCT01537575Phase 3
44The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)CompletedNCT01510366Phase 3
45Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) DiseasesCompletedNCT01472263Phase 3
46Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio VaccineCompletedNCT01457560Phase 3
47Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered SeparatelyCompletedNCT01457508Phase 3
48Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy InfantsCompletedNCT01444781Phase 3
49Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in JapanCompletedNCT01389687Phase 3
50Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) VaccineCompletedNCT01353703Phase 3

Search NIH Clinical Center for Myelitis


Cochrane evidence based reviews: myelitis

Genetic Tests for Myelitis

About this section

Anatomical Context for Myelitis

About this section

MalaCards organs/tissues related to Myelitis:

33
Spinal cord, Brain, Lung, Liver, Thyroid, Breast, Bone

Animal Models for Myelitis or affiliated genes

About this section

MGI Mouse Phenotypes related to Myelitis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053917.8AQP4, ITGB3, MBP, MOG, MTHFR

Publications for Myelitis

About this section

Articles related to Myelitis:

(show top 50)    (show all 869)
idTitleAuthorsYear
1
Teaching NeuroImages: Longitudinally extensive transverse myelitis in MELAS. (26810428)
2016
2
Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis. (26608499)
2016
3
Cervical spinal cord atrophy in NMOSD without a history of myelitis or MRI-visible lesions. (27144215)
2016
4
Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome. (26050233)
2015
5
Longitudinally extensive transverse myelitis with anti-NMDA receptor antibodies during a systemic lupus erythematosus flare-up. (26611483)
2015
6
Protocol for a multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin versus standard therapy for the treatment of transverse myelitis in adults and children (STRIVE). (26009577)
2015
7
Predictors of recurrence following an initial episode of transverse myelitis. (25340060)
2014
8
Transverse myelitis associated with an itchy rash and hyperckemia: neuromyelitis optica associated with dermatitis herpetiformis. (24637913)
2014
9
An acute transverse myelitis attack after total body irradiation: a rare case. (23984124)
2013
10
Extensive myelitis associated with anti-NMDA receptor antibodies. (24373538)
2013
11
The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis. (24307005)
2013
12
Pulse-triggered DTI sequence with reduced FOV and coronal acquisition at 3T for the assessment of the cervical spinal cord in patients with myelitis. (22918433)
2013
13
Human herpes virus 6-associated myelitis following allogeneic bone marrow transplantation. (22415068)
2012
14
Diagnosis and treatment of pediatric acute transverse myelitis. (23814937)
2012
15
Zoster myelitis in sickle cell anemia. (22246022)
2012
16
Acute transverse myelitis and acute motor axonal neuropathy developed after vaccinations against seasonal and 2009 A/H1N1 influenza. (21372468)
2011
17
Stiff leg syndrome and myelitis with anti-amphiphysin antibodies: a common physiopathology? (21986240)
2011
18
Neuromyelitis optica spectrum disorder in patients with connective tissue disease and myelitis. (21523924)
2011
19
Epstein-Barr virus myelitis and Castleman's disease in a patient with acquired immune deficiency syndrome: a case report. (21615962)
2011
20
Seropositive antiaquaporin-4 antibody associated with multisegmental myelitis in a patient with paracoccidioidomycosis. (21803375)
2011
21
Mycoplasma pneumoniae--associated transverse myelitis and rhabdomyolysis. (19135630)
2009
22
Verminous myelitis in a pit bull puppy. (19407100)
2009
23
Longitudinal myelitis, aseptic meningitis, and conus medullaris infarction as presenting manifestations of pediatric systemic lupus erythematosus. (18413416)
2008
24
Varicella zoster virus meningo-encephalo-myelitis in an immunocompetent patient. (18810606)
2008
25
A case of anti-aquaporin-4 and anti-glutamate receptor antibodies positive myelitis presented with modest clinical signs. (18460850)
2008
26
Transverse myelitis following general and epidural anaesthesia in a paediatric patient. (16115254)
2005
27
Acute transverse myelitis and hepatitis C virus. (15888983)
2005
28
Percutaneous embolisation and transverse myelitis: a rare association. (15366806)
2004
29
Anterior horn cell involvement in myelitis with atopic diathesis (atopic myelitis). (15101198)
2004
30
Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome. (12741480)
2003
31
Multiphasic demyelinating disorder with acute transverse myelitis in Japanese. (12814118)
2003
32
Necrotizing myelitis in an immunocompetent child: a case report with review of literature. (14701948)
2003
33
Non-progressive viral myelitis in X-linked agammaglobulinemia. (11891104)
2002
34
Transverse myelitis associated with herpes simplex virus infection. (11732777)
2001
35
Absence of cervical radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck. (11710599)
2001
36
Decrease in multiple sclerosis with acute transverse myelitis in Japan. (10494904)
1999
37
MR imaging of acute transverse myelitis. (10224833)
1999
38
Absence of thoracic radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for Stage III nonsmall-cell lung cancer. (9457819)
1998
39
A case of acute transverse myelitis affecting the entire length of the spinal cord. (9208267)
1997
40
Postural hypotension in a patient with acute myelitis. (8731714)
1996
41
Local stem cell depletion model for radiation myelitis. (3384725)
1988
42
Hyperbaric oxygen therapy for radiation myelitis. (4082347)
1985
43
Transverse myelitis due to meningovascular syphilis. (6696656)
1984
44
Leads from the MMWR. Acute schistosomiasis with transverse myelitis in American students returning from Kenya. (6471329)
1984
45
Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis. (6610427)
1984
46
Syphilitic Meningo-Myelitis: Erysipelas: Recovery. (20759725)
1901
47
48
49
50

Variations for Myelitis

About this section

Expression for genes affiliated with Myelitis

About this section
Search GEO for disease gene expression data for Myelitis.

Pathways for genes affiliated with Myelitis

About this section

GO Terms for genes affiliated with Myelitis

About this section

Biological processes related to Myelitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1positive regulation of triglyceride catabolic processGO:001089810.0APOA1, APOH
2positive regulation of lipoprotein lipase activityGO:005100610.0APOA1, APOH
3integrin-mediated signaling pathwayGO:00072299.8ITGA2B, ITGB3
4platelet degranulationGO:00025769.7APOA1, APOH
5cell adhesionGO:00071559.0ITGA2B, ITGB3, MOG

Sources for Myelitis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet